Senti Biosciences, Inc. (SNTI)

NASDAQ: SNTI · Real-Time Price · USD

1.100

+0.138 (14.38%)

At close: Apr 17, 2026, 4:00 PM EDT

1.090

-0.010 (-0.91%)

After-hours: Apr 17, 2026, 7:58 PM EDT

Senti Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	16.42	48.28	35.93	57.62	56.03
Short-Term Investments	-	-	-	40.94	-
Cash & Short-Term Investments	16.42	48.28	35.93	98.56	56.03
Cash Growth	-65.99%	34.38%	-63.55%	75.90%	83.49%
Accounts Receivable	0.32	0.16	0.11	0.63	0.48
Other Receivables	1.27	1.65	18.71	-	-
Total Trade Receivables	1.6	1.81	18.82	0.63	0.48
Other Current Assets	5.26	8.88	17.57	3.39	3.68
Total Current Assets	23.27	58.96	71.2	102.58	60.19
Net Property, Plant & Equipment	24.4	35.24	41.61	69.78	33.08
Long-Term Investments	-	-	1.82	-	-
Other Long-Term Assets	3.55	3.64	3.74	8.43	3.43
Total Assets	51.22	97.84	119.48	180.79	96.7
Accounts Payable	2.94	1.45	1.25	1.37	5.19
Accrued Expenses	5.35	6.39	5.93	12.58	5.33
Current Portion of Leases	5.33	4.65	4.13	1.99	1.74
Unearned Revenue	0.04	-	-	0.8	1.66
Other Current Liabilities	0.3	0.66	1.37	1.32	0.63
Total Current Liabilities	13.97	13.15	12.67	18.05	14.54
Long-Term Leases	23.56	28.89	33.54	35.1	20.99
Other Long-Term Liabilities	8.1	5.05	6.36	0.37	0.8
Total Long-Term Liabilities	31.66	33.94	39.9	35.48	21.78
Total Liabilities	45.63	47.09	52.57	53.53	36.33
Common Stock	0	0	0	0	-
Additional Paid-in Capital	364.16	322.78	311.26	300.54	3.62
Accumulated Other Comprehensive Income	-	-	-	0	-
Retained Earnings	-	-	-244.34	-173.29	-115.08
Total Common Shareholders' Equity	364.16	322.78	66.91	127.26	-111.46
Minority Interest	-	25.11	-	-	171.83
Shareholders' Equity	364.16	347.89	66.91	127.26	60.38
Total Liabilities & Equity	51.22	97.84	119.48	180.79	96.7
Total Debt	28.89	33.54	37.67	37.09	22.73
Net Cash (Debt)	-12.47	14.74	-1.74	61.47	33.3
Net Cash Growth	-	-	-	84.58%	101.98%
Net Cash Per Share	-0.56	3.21	-0.39	23.54	114.35
Book Value	364.16	322.78	66.91	127.26	-111.46
Book Value Per Share	16.20	70.23	15.08	48.74	-382.71
Tangible Book Value	364.16	322.78	66.91	127.26	-111.46
Tangible Book Value Per Share	16.20	70.23	15.08	48.74	-382.71

Updated Mar 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q